Elekta

Attending #ISRS2026 in Sydney? Join our Lunch Symposium to explore how innovations in stereotactic radiotherapy are expanding treatment possibilities, including new indications, alternative fractionation approaches, and improved workflow efficiency. Save your spot 👉 bit.ly/3RRyng4

Highlights from #ESTRO26! ☕️ If you missed our Coffee & Connect sessions at the booth, here are a few key insights and perspectives shared by Prof. Dr Chian Gani, Dr. Matthias Lampe, Dr. Hui Khee Looe and Dr. Erwin Wiegman – covering innovation, clinical experience and the future of radiotherapy.

New findings in glioblastoma show how MR‑guided adaptive radiotherapy can reduce treatment volumes by 40% while maintaining outcomes and a 4% marginal failure vs 11% historically. A step forward in delivering precise care and helping protect healthy brain tissue. 👉 Read the full study in The Lancet Oncology: bit.ly/4tLKIzT *Study by Detsky et al., UNITED trial investigators at Sunnybrook Health Sciences Centre.

A heartfelt thank you to everyone, both near and far, who spent time with us at #ESTRO26. We are grateful for the opportunity to connect in person and look forward to seeing you next year in Milan, Italy!

Which topic has been your key focus at #ESTRO26?

Emerging evidence presented at #ESTRO26 highlights advances in MR-guided adaptive radiotherapy across multiple cancer indications. Read more in today’s press release ➡️ bit.ly/49A6eAg

The #ESTRO26 exhibit hall is open for one more day! Don’t miss the chance to explore how our adaptive solutions can benefit you, your patients and your clinic. Bonus: it's been said we have the best coffee around. ☕ 🍩

God morgon! 👋 Come by our booth and book a demo! #ESTRO26

The correct answer: Professor Lars Leksell invented the concept of stereotactic radiosurgery in 1951, which is the same year the Leksell Gamma Knife was born.

Innovation has a hometown. Stereotactic radiosurgery was born in Stockholm! #ESTRO26

Do you know what year it all began?

It was a pleasure to connect with customers, colleagues and friends today at #ESTRO26. If you missed us, don't worry, there's still plenty to explore tomorrow at Elekta booth C10:87.

Live from #ESTRO26 with a message from our CEO, Jakob Just-Bomholt.

Discover how adaptive approaches are expanding access to precision treatment and shaping the future of #radiotherapy delivery. Join us today at #ESTRO26 in Stockholm for our Lunch Symposium.

#ESTRO26 is officially underway in Stockholm, Sweden! Over the next few days, follow along to find out how our solutions can help you continue to make a world of difference for your patients and your clinic.

Meet us at #ESTRO26 👋

Discover how adaptive approaches are expanding access to precision treatment and shaping the future of #radiotherapy delivery. Join us at #ESTRO26 in Stockholm for our Lunch Symposium. Register now ➡️ bit.ly/4tdS1Re

May is Skin Cancer Awareness Month. In clinical practice, multiple factors guide treatment decisions, but priorities can vary.
What influences your decision to use brachytherapy for skin cancer?

Meet us at #ESTRO26! Book a personalized demo, explore the clinical area that matters most to you and see our systems live in action with dedicated time from our team. ➡️ bit.ly/4wbAfzW 📍 Stockholmsmässan | Booth C10:87

Just 20g of Cobalt‑60 power a Leksell Gamma Knife to deliver highly precise intracranial radiosurgery. For decades, this cobalt based platform has set the gold standard with steep dose gradients, low scatter & minimal healthy‑tissue exposure. ▶️ bit.ly/42iwJGm

April is #HeadandNeckCancerAwareness month. How widely is adaptive radiotherapy being used for head & neck cancer in your practice?